0001209191-15-045582.txt : 20150521 0001209191-15-045582.hdr.sgml : 20150521 20150521182858 ACCESSION NUMBER: 0001209191-15-045582 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150519 FILED AS OF DATE: 20150521 DATE AS OF CHANGE: 20150521 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000949858 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 954343413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19820 NORTH CREEK PARKWAY STREET 2: SUITE 201 CITY: BOTHELL STATE: WA ZIP: 98011 BUSINESS PHONE: 425-686-1500 MAIL ADDRESS: STREET 1: 19820 NORTH CREEK PARKWAY STREET 2: SUITE 201 CITY: BOTHELL STATE: WA ZIP: 98011 FORMER COMPANY: FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cormack Scott Daniel CENTRAL INDEX KEY: 0001442675 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 033-80623 FILM NUMBER: 15884056 MAIL ADDRESS: STREET 1: 400-1001 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V6H 4B1 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-19 0 0000949858 ONCOGENEX PHARMACEUTICALS, INC. OGXI 0001442675 Cormack Scott Daniel 400-1001 W. BROADWAY VANCOUVER A1 V6H 4B1 BRITISH COLUMBIA, CANADA 1 1 0 0 President and CEO Common Stock 2015-05-19 4 M 0 15624 0.00 A 114681 D Common Stock 2015-05-20 4 S 0 7543 1.88 D 107138 D Restricted Stock Unit (RSU) 2015-05-19 4 M 0 4687 0.00 D 2016-01-31 Common Stock 4687 4687 D Restricted Stock Unit (RSU) 2015-05-19 4 M 0 4687 0.00 D 2017-01-31 Common Stock 4687 9375 D Restricted Stock Unit (RSU) 2015-05-19 4 M 0 6250 0.00 D 2018-04-13 Common Stock 6250 18750 D Stock Option (right to buy) 1.86 2015-05-19 4 A 0 75000 0.00 A 2025-05-19 Common Stock 75000 75000 D Restricted Stock Unit (RSU) 2015-05-19 4 A 0 37500 0.00 A 2019-06-18 Common 37500 37500 D Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Represents shares of common stock that have been sold by the issuer to satisfy the tax liability in connection with the settlement of RSUs. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest on March 12, 2013 and then annually on the later of: (i) each anniversary of January 1, 2012; and (ii) the first day thereafter during which the issuer's trading window is open. Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2013; and (ii) the first day thereafter during which the issuer's trading window is open. Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2014; and (ii) the first day thereafter during which the issuer's trading window is open. The options vest in monthly installments over 48 months commencing one month from January 1, 2015. Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2015; and (ii) the first day thereafter during which the issuer's trading window is open. Sandra Thomson as attorney-in-fact for Scott Cormack 2015-05-21